French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced its acquisition of UK-based biotech firm Vicebio in a deal ...

Adult-onset Still's Disease (AOSD) is a rare, systemic inflammatory disorder characterized by high fevers, rashes, and arthritis, impacting adults wi ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of ...

On Thursday, 2007 stocks advanced, 2040 declined and 152 remained unchanged on Bombay Stock Exchange with advance decline ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Dear reader, over the past decade, Saudi Arabia has undertakenan ambitious overhaul of its healthcare and life sciences ...

Discover the future of CD123 Targeting Therapies with our Global Market Trends & Outlook 2025 report. Examine clinical trials, technology innovations, and market dynamics as this field expands from ...

The Idiopathic Thrombocytopenic Purpura market is poised for significant expansion through 2032, underpinned by rising disease awareness, improving epidemiological understanding, and a vibrant ...